These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 1835568)

  • 21. Comparison of mutant frequencies at the transgenic lambda LacI and cII/cI loci in control and ENU-treated Big Blue mice.
    Zimmer DM; Harbach PR; Mattes WB; Aaron CS
    Environ Mol Mutagen; 1999; 33(3):249-56. PubMed ID: 10334627
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Spontaneous mutants recovered from liver and germ cell tissue of low copy number lacI transgenic rats.
    de Boer JG; Erfle H; Holcroft J; Walsh D; Dycaico M; Provost S; Short J; Glickman BW
    Mutat Res; 1996 Jun; 352(1-2):73-8. PubMed ID: 8676919
    [TBL] [Abstract][Full Text] [Related]  

  • 23. PAP: detection of ultra rare mutations depends on P* oligonucleotides: "sleeping beauties" awakened by the kiss of pyrophosphorolysis.
    Liu Q; Sommer SS
    Hum Mutat; 2004 May; 23(5):426-36. PubMed ID: 15108273
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Analysis of spontaneous and induced mutations in transgenic mice using a lambda ZAP/lacI shuttle vector.
    Kohler SW; Provost GS; Fieck A; Kretz PL; Bullock WO; Putman DL; Sorge JA; Short JM
    Environ Mol Mutagen; 1991; 18(4):316-21. PubMed ID: 1836179
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [A new strategy for detecting Lac I mutants based on pMCLac I/neo transgenic mice].
    Yao ZZ; Li HX; Che WL; He Y; Fu JL
    Yi Chuan Xue Bao; 2002 Jul; 29(7):589-93. PubMed ID: 12143306
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Use of transgenic mice for assessing the mutagenicity of 1,3-butadiene in vivo.
    Recio L; Bond JA; Pluta LJ; Sisk SC
    IARC Sci Publ; 1993; (127):235-43. PubMed ID: 8070869
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Lambda Select cII Mutation Detection System.
    Besaratinia A; Tommasi S
    J Vis Exp; 2018 Apr; (134):. PubMed ID: 29757290
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficient method for mapping and characterizing structures of deletion mutations in gpt delta mice using Southern blot analysis with oligo DNA probes.
    Shibata A; Masutani M; Kamada N; Masumura K; Nakagama H; Kobayashi S; Teraoka H; Suzuki H; Nohmi T
    Environ Mol Mutagen; 2004; 43(3):204-7. PubMed ID: 15065208
    [No Abstract]   [Full Text] [Related]  

  • 29. Genetic instability induced by the tumor microenvironment.
    Reynolds TY; Rockwell S; Glazer PM
    Cancer Res; 1996 Dec; 56(24):5754-7. PubMed ID: 8971187
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genetic instability favoring transversions associated with ErbB2-induced mammary tumorigenesis.
    Liu S; Liu W; Jakubczak JL; Erexson GL; Tindall KR; Chan R; Muller WJ; Adhya S; Garges S; Merlino G
    Proc Natl Acad Sci U S A; 2002 Mar; 99(6):3770-5. PubMed ID: 11867754
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Background mutations and polymorphisms in lacZ-plasmid transgenic mice.
    Dollé ME; Snyder WK; van Orsouw NJ; Vijg J
    Environ Mol Mutagen; 1999; 34(2-3):112-20. PubMed ID: 10529734
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genomic sequences of bacteriophages HK97 and HK022: pervasive genetic mosaicism in the lambdoid bacteriophages.
    Juhala RJ; Ford ME; Duda RL; Youlton A; Hatfull GF; Hendrix RW
    J Mol Biol; 2000 May; 299(1):27-51. PubMed ID: 10860721
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Temporal and molecular characteristics of lacZ mutations in somatic tissues of transgenic mice.
    Douglas GR; Jiao J; Gingerich JD; Soper LM; Gossen JA
    Environ Mol Mutagen; 1996; 28(4):317-24. PubMed ID: 8991059
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Investigating DNA adduct-targeted mutagenicity of tamoxifen: preferential formation of tamoxifen-DNA adducts in the human p53 gene in SV40 immortalized hepatocytes but not endometrial carcinoma cells.
    Besaratinia A; Pfeifer GP
    Biochemistry; 2005 Jun; 44(23):8418-27. PubMed ID: 15938631
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Plasmid rescue from transgenic mouse DNA using LacI repressor protein conjugated to magnetic beads.
    Gossen JA; de Leeuw WJ; Molijn AC; Vijg J
    Biotechniques; 1993 Apr; 14(4):624-9. PubMed ID: 8476606
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Use of transgenic mouse models for studying somatic mutations in aging.
    Martus HJ; Dollé ME; Gossen JA; Boerrigter ME; Vijg J
    Mutat Res; 1995 Oct; 338(1-6):203-13. PubMed ID: 7565876
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The use of transgenic mice for short-term, in vivo mutagenicity testing.
    Kohler SW; Provost GS; Kretz PL; Fieck A; Sorge JA; Short JM
    Genet Anal Tech Appl; 1990 Dec; 7(8):212-8. PubMed ID: 2151115
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Analysis of genetic instability during mammary tumor progression using a novel selection-based assay for in vivo mutations in a bacteriophage lambda transgene target.
    Jakubczak JL; Merlino G; French JE; Muller WJ; Paul B; Adhya S; Garges S
    Proc Natl Acad Sci U S A; 1996 Aug; 93(17):9073-8. PubMed ID: 8799156
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Quantifying in vivo somatic mutations using transgenic mouse model systems.
    Swiger RR
    Methods Mol Biol; 2005; 291():145-53. PubMed ID: 15502219
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficient rescue of integrated shuttle vectors from transgenic mice: a model for studying mutations in vivo.
    Gossen JA; de Leeuw WJ; Tan CH; Zwarthoff EC; Berends F; Lohman PH; Knook DL; Vijg J
    Proc Natl Acad Sci U S A; 1989 Oct; 86(20):7971-5. PubMed ID: 2530578
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.